Orbactiv 400 mg/1
oritavancin · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Melinta Therapeutics, LLC
No Recall History
Plain English
Orbactiv is a injection, powder, lyophilized, for solution containing oritavancin at 400 mg/1, taken intravenous. Manufactured by Melinta Therapeutics, LLC.
Key Facts
- Brand Name
- Orbactiv
- Generic Name
- oritavancin
- NDC Code (Product)
70842-140- Manufacturer
- Melinta Therapeutics, LLC
- Strength
- 400 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA206334
- Drug Class
- Lipoglycopeptide Antibacterial [EPC]
- Marketing Start
- 09/01/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is Orbactiv used for?
Orbactiv contains oritavancin. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Orbactiv a controlled substance?
Orbactiv is not classified as a controlled substance by the DEA.
What is the generic name for Orbactiv?
The generic name for Orbactiv is oritavancin. There are 1 other brand versions of oritavancin.
What is the NDC code for Orbactiv 400 mg/1?
The NDC (National Drug Code) for Orbactiv 400 mg/1 is 70842-140, listed by Melinta Therapeutics, LLC.